Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lin C–I et al. – Gal–3 targeted therapy is a promising therapeutic strategy for advanced PTC that is refractory to surgery and radioactive iodine therapy.

Related Articles

Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the Young
Thyroid, 11/06/09    Relevance Score: 82%

Age disparities in referrals to specialist surgical care for papillary thyroid cancer
European Journal of Surgical Oncology, 11/16/09    Relevance Score: 81%

Thyroid Cancer in Systemic Lupus Erythematosus: A Case-Control Study
Journal of Clinical Endocrinology and Metabolism, 11/12/09    Relevance Score: 81%

Adult onset Stills disease diagnosed concomitantly with occult papillary thyroid cancer: paraneoplastic manifestation or coincidence
Clinical Rheumatology, 11/12/09    Relevance Score: 80%

Real-time Elastography and Contrast-Enhanced Ultrasound for the Assessment of Thyroid Nodules
Experimental and Clinical Endocrinology & Diabetes, 11/02/09    Relevance Score: 80%

Today in Basic Science/Genetics...keeping you current

Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies
Diabetic Medicine, 11/24/09

Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors
Molecular and Cellular Endocrinology, 11/24/09

Association between interleukin-1 beta polymorphism (+3953) and obesity
Molecular and Cellular Endocrinology, 11/24/09

Today in Endocrine Oncology...keeping you current

Limited Value of 18F-F-DOPA PET to Localize Pancreatic Insulin-Secreting Tumors in Adults with Hyperinsulinemic Hypoglycemia
Journal of Clinical Endocrinology and Metabolism, 11/24/09

Occult lymph node metastases in neck level V in papillary thyroid carcinoma
Surgery, 11/24/09

Medullary Thyroid Carcinoma Cell Lines Contain a Self-Renewing CD133+ Population that Is Dependent on Ret Proto-Oncogene Activity
Journal of Clinical Endocrinology and Metabolism, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address